Cancer Research DivisionBMC CancerYu XQ, De Angelis R, Luo Q, Kahn C, Houssami N, O'Connell DL. A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer. BMC Cancer. 2014; 14: 936....
Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis Breast cancer metastasis to the brain is rising in prevalence and is an increasingly lethal threat to the patients. Here, the authors show miR-199b-5p, secreted by some breast cancer cells and...
Abortion and breast cancer risk for Australian women. Kelly-Anne,Phillips,Fiona,... - 《Medical Journal of Australia》 被引量: 5发表: 2014年 Abortion history and breast cancer risk: Results from the Shanghai breast cancer study Studies of the association between induced abortion and breast ...
falling; (b) higher proportion of cases of both incident and recurrent cancer being deemed treatable, with treatment regimes becoming progressively more complex; and (c) improving outcomes of treatment, expanding the pool of survivors (Australian Institute of Health and Welfare & Cancer Australia, ...
US Cancer Statistics Data Visualizations Tool, based on 2022 submission data (1999-2020). Centers for Disease Control and Prevention. Updated June 2023. Accessed July 31, 2023. https://www.cdc.gov/cancer/dataviz 3. Cancer Statistics Explorer Network. Breast cancer: SEER incidence rates by age...
Purpose: This study investigated (1) the prevalence of pain following breast cancer treatment including moderate-to-severe persistent pain and (2) the association of risk factors, present 1 month following surgery, with pain at 21 months following surgery. This information may aid the development ...
International research suggests complementary therapy usage is common in women with breast cancer. Comparable data do not exist for Australia. A self-completed questionnaire was used to survey Australian women with breast cancer about their usage of complementary therapies. The survey was mailed to memb...
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genet Med. 2015;17(8):630-638.PubMedGoogle ScholarCrossref 47. Goldstein LJ, Gray R, Badve S, et al. Prognostic utility of the 21-gene assay in ...
The tumour immune microenvironment is shaped by the crosstalk between cancer cells, immune cells, fibroblasts, endothelial cells and other stromal components. Although the immune tumour microenvironment (TME) serves as a source of therapeutic targets, it is also considered a friend or foe to tumour-...
The main aim of this study was to determine the prevalence of unmet needs women who had had previous treatment (with curative intent) for early stage breast cancer. The impetus to do this came from the changes in model of care in the UK, which mean that in many breast units these women...